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Tyrosinases catalyze two initial reaction steps in the formation of melanin. Puriﬁcation of tyrosinases had
always been a process accompanied with various problems caused by enzymatic browning processes.
Here, an approach is presented for the puriﬁcation of the latent enzyme from mushrooms which averts
and removes interfering compounds (e.g. polyphenols) in advance to the extraction process. The
described method is supposed being well suitable as a general protein puriﬁcation protocol from natural
sources like fungi and plants.
The puriﬁed enzyme was investigated in detail by means of mass spectrometry: its intact protein mass
was determined as 64,247.3 Da and it was identiﬁed as number four of in total six isoforms (PPO1–6) by
means of sequence analysis. Some PTMs, strain speciﬁc sequence disparities and several cleavage sites
including the one causing enzyme-activation (Ser383) were determined, thus, providing insights on the
maturation process of this latent tyrosinase zymogen. Based on these sequence data it can be concluded
that the polypeptide backbone of the latent form of the tyrosinase PPO4 ranges from Ser2 to Thr565, miss-
ing when compared to the gene-derived sequence a small part (46 amino acids) of the C-terminal tail. The
high content on hydrophobic amino acids within this missing tail gives rise to speculations whether this
part might have a function as a membrane anchor.
 2014 The Authors. Published by Elsevier Ltd. Open access under CC BY license.Introduction (Chang, 2009; Khan, 2007; Kim and Uyama, 2005; Schurink et al.,Tyrosinase (EC 1.14.18.1; EC 1.10.3.1) is an enzyme which is
distributed over a wide range of organisms from bacteria, fungi,
and plants to mammals (Mayer, 2006; Oetting, 2000). It catalyzes
the ﬁrst reaction steps in the formation of the polyphenolic pig-
ment compounds known as melanins (Sánchez-Ferrer et al.,
1995; Seo et al., 2003). These pigments are formed during senes-
cence of agricultural products lowering signiﬁcantly their disposal
value. To oppose this matter a lot of effort has been put into eluci-
dating the functional and structural properties of this enzyme.
Numerous attempts have been performed to ﬁnd appropriate
inhibitors against the enzyme’s activity in respect on functionality,
toxicity, availability and expense, however with minor success2007).
Currently the amino acid sequences of six polypeptides (PPO1
to 6) are known for a polyphenol oxidase originating from Agaricus
bisporus (Genome Sequence, n.d.; Weijn et al., 2013; Wichers et al.,
2003; Wu et al., 2010). It is known that the protein exists as a
zymogen, also described as the latent form (L-TYR, named pro-
tyrosinase by others (Fujieda et al., 2013)), and an active form
(A-TYR) (for a schematic illustration see Scheme 1) (Bouchilloux
et al., 1963; Mallette and Dawson, 1949; Yamaguchi et al., 1970).
The mature active form is generated by proteolytic cleavage of
the latent form, by which the C-terminal part of the protein is re-
moved and the previously buried active site becomes exposed
(Faccio et al., 2013; Fujieda et al., 2012). An artiﬁcial activation
can be achieved due to the use of detergents (Espín and Wichers,
1999; Moore and Flurkey, 1990). Recently, homology models of
PPO1, 2, 4, 5 were published (Inlow, 2012) which in all cases pre-
dict an orientation of the C-terminal chain in a way shielding the
active site. Thus, for the purpose of developing a commercially
relevant technology for suppressing the enzymatic browning
reactions, the putative more promising way could be a strategy
of hindering the proteolytic activation process itself rather than
Scheme 1. Schematic illustration of the polypeptide chain of PPO4 mushroom tyrosinase. The polypeptide chain of active tyrosinase (core-region) is colored in red. It ranges
from Ser2 to the determined cleavage site at Ser383. This A-TYR part contains both copper binding sites forming the active site as well as the thioether bridge between Cys80 to
His82. The C-terminal part is colored in orange. It starts with position Glu384 and ends with the cleavage site at Thr565. The untraceable C-terminal tail above Thr565 is colored
purple. Amino acids of this part were not found during this investigation. Computer based structure modeling of this sequence tail suggests the presence of a trans-membrane
helix between Ala569 and Ala591. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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knowledge of the crystal structure of the latent tyrosinase would
be beneﬁcial as it was shown before for pro-tyrosinase from Asper-
gillus oryzae (Fujieda et al., 2013) and a closely related type-3 cop-
per protein from Manduca sexta (Li et al., 2009).
Recently, the ﬁrst crystal structure of an active eukaryotic tyros-
inase (A. bisporus) was published (Ismaya et al., 2011). The protein
was found being present in a complex as described earlier
(Strothkamp et al., 1976) consisting of two heavy (H) and two light
subunits (L) forming a tetramer of the type (H2L2). The heavy sub-
unit containing the active site corresponds to the amino acids 2 to
392 from the polyphenol oxidase 3 (PPO3) sequence which covers
in toto 576 residues (Wu et al., 2010). The investigated enzyme was
found being in the deoxy state (Solomon et al., 1996). Interestingly,
the heavy subunit shows ‘‘stand alone’’ activity. No evidence was
found for the presence of the C-terminal part (residues 393–576)
of the protein. The small subunit, L, corresponds to ORF239342
found in the 2010 generated genome sequence of A. bisporus (Gen-
ome Sequence, n.d.). Neither its cell based origin (or whether it’s an
artiﬁcial protracted protein during the puriﬁcation process), nor
the function of this lectin like fold small protein could be clariﬁed
by the authors (Ismaya et al., 2011).
Isolation and puriﬁcation of mushroom tyrosinase is a process
known over long time and well developed, however, only up to a
certain point of purity (Espín and Wichers, 1999; Fan and Flurkey,
2004; Haghbeen et al., 2004; Nelson and Mason, 1970). It is readily
feasible to get highly active protein extracts, however, these ex-
tracts are heterogeneous in composition (with respect to protein
isoforms and particularly impurities), are instable and their activity
determination is hardly reproducible (Flurkey et al., 2008; Flurkey
and Inlow, 2008; Rescigno et al., 2007). Such tyrosinase extracts
are also commercially available (Sigma–Aldrich). Preventing sample
heterogeneity when preparing these extraction products is a
challenging task because of several reasons outlined below.
First, at the genetic level, six different isoforms exist of the en-
zyme, i.e. PPO1 to 6 (Weijn et al., 2013; Wichers et al., 2003; Wu
et al., 2010). Most likely, all of them are proteolytically processed,
which results in differing active and latent forms. Expression stud-
ies have shown (Li et al., 2011; Weijn et al., 2013) that these differ-
ent isoforms (PPO1–6) are expressed in different quantities
depending on the growth-stage and the fruit-body compartment
(e.g. cap, stipe) (Hammond and Nichols, 1976). Second, the forma-
tion of the active form of the protein by proteolytic cleavage starts
immediately after cell lysis forming great numbers of active
tyrosinase species as well as huge amounts of colored compounds
(e.g. melanins). This process is hardly preventable. In addition, theaccruing heterogeneity of the protein might be due to further
unspeciﬁc cleavages, post translational modiﬁcations and pro-
tein–protein aggregation. Third, tyrosinase is known for protein
cross-linking as well as for its potential of oxidizing protein back-
bone tyrosines (Gieseg et al., 1993; Jus et al., 2011; Thalmann and
Lötzbeyer, 2002). Recently, cross-links in recombinant tyrosinase
of A. oryzae has been conﬁrmed by means of mass spectrometry
(MS) (Fujieda et al., 2012). Protein aggregation and backbone tyro-
sine oxidation conceivably are reasons for the observed post-
browning effect which occurs reproducibly after removing reducing
agents by e.g. size exclusion chromatography (SEC) and temporal
storage of the protein in solution (Sojo et al., 1998). Another major
reason for inhomogeneity, instability and irreproducibility of tyros-
inase extracts lies in the difﬁculty to remove the brown colored
compounds generated by oxygen exposure after cell disruption
(Espín and Wichers, 1999; Wichers et al., 1996; Zhang and Flurkey,
1999). Such pigments are formed by polymerization of quinones.
These quinones and their polymerized products are known to form
protein–protein aggregates, cause protein precipitation, simply
bind to proteins and also color and disable chromatographic mate-
rials irreversibly (Fujieda et al., 2012;McManus et al., 1981). Hence,
it can be argued that the occurring browning reactions are not pur-
posed to retain cell functionality than rather stiﬂe all functional
processes including pathogenic ones (Bell and Wheeler, 1986).
Therefore, it is reasonable to oppose tyrosinase activation and sub-
sequent browning processes in order to isolate and purify proteins
in their physiological homogenous forms.
In this work a new and signiﬁcantly improved approach for iso-
lating and purifying latent mushroom tyrosinase will be presented
which focuses on averting the formation of interfering pigments
and their subsequent products and/or on removing them.Moreover,
the presented method achieves protein homogeneity by separating
occurring isoforms. The extraction approach is partially based on a
method published elsewhere but is modiﬁed and optimized in sev-
eral respects (Sojo et al., 1998). The method described in this paper
allows a very efﬁcient separation of L-TYR from A-TYR. After puriﬁ-
cation to proximate homogeneity the protein could be identiﬁed
and characterized by MS based methodology providing sequence
information, precise cleavage positions and the accurate mass of
the intact protein (A-TYR and L-TYR) with its fringed C-terminus
expounding another conclusion for protein heterogeneity. Several
modiﬁcations as well as severe sequence disparities (point-
mutations) due to differing strain origin could be determined by
means of MS data. In addition, some predictions regarding
secondary structures and membrane embedding which are based
on computational model calculations will be added.
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Initial sample preparation, extraction and processing
The pre-extraction method was aimed at preparing a lyophi-
lized mushroom powder. An efﬁcient cell disruption (effected by
using high amounts of triton-X114 (8%) and by repetitive mixing
steps) led to high amounts of protein accessible for the subsequent
extraction. The pre-extraction including a treatment with a highly
concentrated PEG solution (proteins not soluble) led to an inten-
sely colored supernatant containing colored compounds and puta-
tive natural tyrosinase substrates. The triton-X114 phase
separation together with the repetitive PEG phase separations
were able to brighten up the protein solution step by step by
decreasing the pigment content of the sample. The chosen pH-va-
lue of 5.3 of the extraction buffer supported this de-coloring pro-
cess and prevented also post browning after removal of sodium
ascorbate by SEC.Chromatographic puriﬁcation (FPLC)
The entire chromatographic puriﬁcation procedure consisted of
four subsequent steps. For the ﬁrst step a SEC column was directly
connected to an anion exchange (AEX) column ﬁlled with DEAE–
Sepharose. The applied SEC method can be considered as the ﬁnal
step for removing interfering low molecular weight compounds
including the remaining ammonium sulfate. The AEX run was
operated by a 3-step elution program with increasing ionic
strength established a fast and rough removal of non-target pro-
teins including proteases (chromatogram not shown). The target-
protein eluted in the middle step with 0.2 M sodium chloride.
The direct connection of SEC with AEX enhanced the recovery of
the latent form, L-TYR. In the subsequent AEX run with Q-Sephar-
ose as stationary phase, two major fractions exhibiting tyrosinase
activity were monitored (Fig. 1A). Activity measurements of the
pooled fractions belonging to the earlier eluted peak (indicated
with ‘‘PPO4’’ in Fig. 1A) showed a high grade of latency (93%).
These fractions were used for further puriﬁcation. The pooled frac-
tions of the second peak (indicated with ‘‘PPO(X)’’ in Fig. 1A)
showed rather low latency (12%) and probably contained other ac-
tive isoforms (e.g. PPO3); they were discarded. Peak one was sub-
jected to a subsequent high-resolution cation exchange (CEX)
puriﬁcation step, using MonoS as stationary phase. This procedure
led to the separation of three different forms of L-TYR (#1, #2, #3
in Fig. 1B), while A-TYR was found in the pass through fractions
(lower pI, see Table 19c in Supporting information). The ﬁrst of
these peaks, #1, was collected and further puriﬁed by a ﬁnal chro-
matographic step consisting of high resolution AEX chromatogra-
phy using a MiniQ stationary phase (Fig. 1C). After this step the
protein was used for the subsequent structural characterization
experiments.
Applying this extraction and puriﬁcation method to 300 g (stan-
dard batch) of lyophilized mushrooms (stipes) yields approxi-
mately 2 mg of L-TYR isoform PPO4. Notably, also A-TYR (1–
2 mg) and other species of the enzyme (e. g. PPO(X) and #2, #3
in Fig. 1A/B) are co-puriﬁed.Enzymatic activity assay
The enzymatic monophenolase activity of this puriﬁed tyrosi-
nase form (L-TYR) towards L-tyrosine as substrate showed a
latency grade of 93% (Fig. 1D) (using for the determination of the
latency a comparison between SDS and non-SDS containing
environments).Gel electrophoresis
SDS–PAGE analysis of the ﬁnally puriﬁed L-TYR revealed the
presence of one single band only (Fig. 2A) with a molecular mass
of approximately 62 kDa. However, A-TYR in comparison showed
still little contamination with some L-TYR species and a mass of
about 44 kDa (Fig. 2B) as well as some faint bands at lowmolecular
masses.
Protein identiﬁcation and sequence conﬁrmation
HPLC–ESI-MS/MS experiments carried out with a LTQ-Orbitrap,
clearly identiﬁed the isolated and puriﬁed protein as PPO4 mush-
room tyrosinase (UniProt.: C7FF05, GenBank: ACU29458.1) yield-
ing a score of 468 (10lgP) and a maximum sequence coverage
of 95%. 75 tryptic peptides were identiﬁed by accurate matching
of the molecular mass (the large majority within 2.5 ppm) and
their MS/MS pattern. They are highlighted gray in Fig. 3 (the com-
prising list is shown in Table 1). Besides almost complete peptide
coverage of the main core region (Ser2–Ser383), also 33 partial over-
lapping peptides in the C-terminal part, deﬁning the enzymes la-
tent form, were found. No tryptic peptides were detected and
identiﬁed beyond Ala574 (Table 1 and Fig. 3). At the C-terminal
end of the protein nearly all possible non-tryptic peptides were
found, i.e., from Asn543–Ala574, suggesting a highly proteolytically
fringed C-terminus. This result was also conﬁrmed by the accurate
mass determination of the intact protein described below. Addi-
tionally, several modiﬁcations were concluded from the tryptic
peptide spectra. All modiﬁcations are marked in Fig. 3. The N-ter-
minal starting peptide (Ser2–Lys14) lacking the Met1 showed a very
high probability (10lgP = 72.2) of being acetylated as was re-
ported for TYR from Neurospora crassa (Lerch et al., 1982). Peptide
Asp69–Arg92 clearly contained the common thioether bridge
(Cys80–His82) found for all known eukaryotic PPOs according to lit-
erature (Gielens et al., 1997; Ismaya et al., 2011). Interestingly, a
mutational isoform seems to be co-existently present in which
eight amino acids are exchanged (see below). Both, mutated as
well as the non-mutated peptides were identiﬁed with high scores
(10lgP) (Table 1). By blasting the mutated PPO4 sequence a per-
fect match with the so far uncharacterized protein K9I869 (Uni-
Prot.) derived from the A. bisporus genome sequence of strain
H97 could be established (Morin et al., 2012). The only two cyste-
ines able to form a disulﬁde bridge (Cys462–Cys465) were actually
found being present with the ‘‘closed’’ disulﬁde-bridge, i.e. exhibit-
ing a molecular mass of 2.02 Da less than the mass calculated for
the ‘‘open bridge’’ variant. Though in this instance the measured
peptide masses gave a deviation from the calculated values of
25 ppm, the fragment spectrum exhibited several b and y ions
matching with the predicted m/z ratios and provided in this way
evidence for peptide identity.
In addition to the identiﬁcation of the target protein band (L-
TYR) also the faint bands in the A-TYR lane were identiﬁed to clar-
ify if a putative attachment of the small subunit (UniProt: G1K3P4,
Ismaya et al., 2011)) might happen after the removal of the C-ter-
minus. Peptides of PPO4 (main core and C-terminal) as well as of
the small (16.2 kDa) protein abLectin (ABL, UniProt: Q00022, se-
quence coverage: 73%) were found. No peptides corresponding to
the small subunit (Q00022) were detected.
The comprehensive set of protein identiﬁcation data containing
lists of all found peptides is presented in the Supporting
information.
Molecular mass of intact L-TYR
The mass spectrum of the entire protein present in the ﬁnally
puriﬁed L-TYR and A-TYR fractions is given in Fig. 4. It was gained
Fig. 1. Chromatographic separation steps and enzymatic assay. (A) AEX chromatography using Q-Sepharose stationary phase. (B) CEX chromatography using MonoS
stationary phase. (C) AEX chromatography using MiniQ stationary phase. Legend: UV absorbance at 280 nm [mAU], UV absorbance at 345 nm [mAU], activity
[U/mL], gradient [% buffer B], conductivity [mS/cm2] (f = 0.5  grad.). (D) Enzymatic assay of the ﬁnal puriﬁed protein samples (A-TYR, L-TYR) with L-tyrosine as
substrate. (Absorbance vs. time at 305 nm). A-TYR (50 mM potassium phosphate buffer pH 6.5), L-TYR (50 mM potassium phosphate buffer pH 6.5), L-TYR
(10 mM sodium phosphate buffer + 2 mM SDS, pH 6.5).
Fig. 2. Analytic SDS–PAGE. (A) Puriﬁed L-TYR (62 kDa) after MiniQ run. (B) A-TYR (44 kDa) after passing through MonoS column (still containing L-TYR). X? low molecular
weight (15 kDa) bands (ABL, PPO4 fragments). Staining: Coomassie Brilliant Blue. Mw marker [kDa] in the respective left lanes.
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40,000 in this mass range and a mass accuracy of better than
5 ppm. The charge state distributions depicted in panel (a) of
Fig. 4A (ranging from about 50 to up to more than 80 charges) indi-
cate the presence of one major protein species (B, when assorting
by increasing Mr) and four minor abundant ones (A, C–E) with sig-
nal intensity ratios of about 6:1. A zoomed-in section of this spec-
trum is shown in Fig. 4B. The magniﬁed panel (b) in Fig. 4B shows
unambiguously that each species peak has a shoulder caused by apreceding peak (Dm 16 Da). For the deconvolution of the charge
state distribution shown in panel (a) of Fig. 4A, 28 distinct peaks
were used for the major species B, and at least 17 peaks with suf-
ﬁcient signal to noise ratios for the species A, C–E. Assuming that
these positive charge (z) states are solely caused by the attachment
of z protons the average molecular masses for the major species B
can be assessed as 64,247.3 Da (STD less than 0.2 Da based on 5
measurements) and for A = 64,034 Da; C = 64,546 Da;
D = 64,647 Da; E = 64,718 Da (STD less than 1.5 Da), respectively.
Fig. 3. Sequence of PPO4. Highlighted are: – tyrosinase common motifs; – copper coordinating histidines; – acetylated N-terminus; / – Mutations (PPO4/K9I869);
– the putative trans-membrane helix; – Peptides identiﬁed by HPLC–ESI-MS/MS are highlighted gray. Red thick lines ( ) indicates the start/end of the L-TYR and A-
TYR sequence, respectively, as deduced from matching with the molecular mass determined for the isolated protein by ESI-QTOF. Black thin lines ( ) indicate the cleavage
positions of the minor sub-species (A, C–E) of L-TYR. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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is likely that the originally present Cu2+ ions are not longer present
in the analyte ions in gas phase. This could be conﬁrmed by non-
acidic sample treatment resulting in a determined mass of approx-
imately 160 Da (2x Cu2+, 1x O22 ) higher. However, the ionization
yield under non-acidic conditions was low. Thus, the thereby
gained data possessed a low signal to noise ratio and were insufﬁ-
cient for accurate mass determination of the Cu containing protein
(see Supporting information).
Calculation of the theoretical average mass of the L-TYR PPO4
isoform consisting of (i) the polypeptide backbone ranging from
Ser2 to Thr565 (taken the sequence conﬁrmed by our sequence
analysis discussed above), (ii) the presence of a thioether bridge
between Cys80 and His82 (reported in the literature for many
type-3 copper proteins i.e. abPPO3, molluscan hemocyanin and
conﬁrmed here) leading to a loss of two H atoms (2.02 Da) as well
as a disulﬁde bridge (2.02 Da), (iii) the presence of an acetylated
N-terminus (+42.01 Da), results in a value of 64,233.2 Da (Gielens
et al., 1997; Ismaya et al., 2011; Klabunde et al., 1998; Wu et al.,
2010).
Taking into account the presence of the eight sequence disparities
of K9I869 to PPO4 (Table 1) (i.e., Val33? Leu (Dm = 14.02 Da),
Ala45? Ser (Dm = 15.99 Da), Val101? Ile (Dm = 14.02 Da), Val121?
Ala (Dm =28.03 Da), Ser179? Asn(Dm = 27.01 Da), Arg188? Lys
(Dm =28.01 Da), Ala207? Gly (Dm =14.02 Da) and Leu391? Gln
(Dm = 14.97 Da)), a total difference between those two isoforms of
15.95 Da is given. The calculated value for the intact mutated PPO4
(K9I869) protein would therefore be 64,249.2 Da. The difference inmass of the mutated (K9I869) and the non-mutated (PPO4) form
matches perfectly to the found shoulder shown in panel (b) of Fig. 4
B (Dm 16 Da).
Comparing the measured mass for species B with the mass cal-
culated for the K9I869 polypeptide under the mentioned condi-
tions, a difference of less than 1.9 Da is found. This difference is
probably owing to a slight shift of the peak maxima due to the
incomplete resolution of the shoulder.
The minor sub-species (A, C–E) are reasonably deduced as pro-
tein forms being proteolytically cleaved at different positions of
the C-terminal polypeptide chain as speciﬁed in Fig. 4B. The mass
differences between these proteolytic species ﬁt accurately to the
amino acids indicated.
ESI mass spectra for A-TYR are shown in Fig. 4C. The estimated
mass for A-TYR is 43,673.1 Da (STD less than 0.5 Da) ﬁtting to the
polypeptide backbone Ser2–Ser383 again accounting a thioether
bridge and an acetylated N-terminus with deviation of 0.2 Da
(PPO4) and 0.8 Da (K9I869), respectively. Other detectable peaks
shown in panel (c) of Fig. 4C correspond to potassium adducts.
Computational structure modeling
From the molecular mass of the isolated ‘‘intact’’ protein as well
as from the sequence analysis it becomes very likely that the major
species’ (B) ﬁnal C-terminal amino acid is Thr565. The sequence of
the following amino acids of PPO4 towards the C-terminus (i.e.
Thr565–Phe611) – this part of the protein is widely missing accord-
ing to the two MS experiments – indicates that this C-terminal part
Table 1
List of peptides (reduced and non-reduced) found by nanoLC–ESI-MS/MS protein identiﬁcation experiments of L-TYR (PPO4). Total 10lgP: 468. (Total score: 2604).a Sequence
coverage: 95%. Solely identiﬁed peptides with lowest divergence [ppm] are listed (For full data set see Supporting information). Peptides beneath the red line are C-terminal
located.
Start/end Sequence -10lgP/Score[a] Mass ppm m/z
2-14 M.S(+42.01)LLATVGPTGGVK.N 72.24 83.21 -1.9 621.36
15-24 K.NRLDIVDFVR.D 1240.70 1245.68 -2.0 623.85
17-24 R.LDIVDFVR.D 76.22 975.54 0.3 488.78
17-24 R.LDIVDFVRDEK.F 75.5 1347.70 -0.8 674.86
28-34 K.FFTLYVR.A 70.87 944.51 -0.7 473.26
28-34 K.FFTLYL(+14.02)R.A 68.7 958.53 -1,0 480,27
35-42 R.ALQAIQDK.D 47.02 885.49 -1.8 443.75
43-68 K.DQADYSSFFQLSGIHGLPFTPWAKPK.D 90.42 2936.45 -2.8 735.12
43-65 K.DQS(+15.99)DYSSFFQLSGIHGLPFTPWAK.P 95,4 2727,30 -0,7 682,83
69-92 K.DTPTVPYESGYCTH(-2.02)SQVLFPTWHR.V 99.57 281.83 -0.2 940.43
93-107 R.VYVSIYEQVLQEAAK.G 123.08 1738.91 -0.1 580.65
93-107 R.VYVSIYEQI(+14.02)LQEAAK.G 104,1 1752,93 -0,5 585,32
118-128 K.KEWVQAAEDLR.Q 76.63 1343.68 -0.1 448.90
118-128 K.KEWA(-28.03)QAAEDLR.Q 88.98 1315.65 -1.2 658.83
119-128 K.EWVQAAEDLR.Q 23.79 1215.59 -2.7 608.80
129-146 R.QPYWDTGFALVPPDEIIK.L 91.72 2088.06 -0.4 1045.04
129-151 R.QPYWDTGFALVPPDEIIKLEQVK.I 25[a] 2673.22 -2.4 896.14
152-159 K.ITNYDGTK.I 47.79 910.44 1.5 456.23
152-163 K.ITNYDGTKITVR.N 35.41 1379.74 -1.7 460.92
164-168 R.NPILR.Y 23.48 611.38 1.2 612.38
169-188 R.YSFHPIDPSFSGYPNFDTWR.T 44.97 2432.09 -3.7 1217.05
169-188 R.YSFHPIDPSFN(+27.01)GYPNFDTWR.T 124.03 2459.10 -0.2 1230.56
169-188 R.YSFHPIDPSFNGYPNFDTWK(-28.01).T 98,8 2431,09 0,1 1216,55
189-199 R.TTVRNPDADKK.E 26[a] 1243.66 2.6 415.56
193-208 R.NPDADKKENIPALIAK.L 60.5 1735.95 -2.2 434.99
199-208 K.KENIPALIG(-14.02)K.L 58,9 1081,65 -1,5 1082,66
199-208 K.KENIPALIAK.L 52.34 1095.67 -2.6 548.84
200-208 K.ENIPALIAK.L 51.16 967.57 -0.4 484.79
209-217 K.LDLEADSTR.E 74.2 1018.49 -0.5 510.25
218-225 R.EKTYNMLK.F 35.88 1025.52 -1.7 513.77
220-225 K.TYNMLK.F 23.4 768.38 -1.9 769.39
226-260 K.FNANWEAFSNHGEFDDTHANSLEAVHDDIHGFVGR.G 78.77 3954.74 -1.6 989.69
265-288 R.GHMTHALFAAFDPIFWLHHSNVDR.H 108.56 2818.36 0.8 564.68
289-308 R.HLSLWQALYPGVWVTQGPER.E 119.27 2336.21 -0.1 779.74
309-322 R.EGSMGFAPGTELNK.D 87.83 1436.66 -1.9 719.34
309-322 R.EGSM(+15.99)GFAPGTELNK.D 109.42 1452.66 -2.2 727.33
309-357 R.EGSMGFAPGTELNKDSALEPFYETEDKPWTSVPLTDTALLNYSYPDFDK.V 48.97 5485.54 1.7 1098.12
323-357 K.DSALEPFYETEDKPWTSVPLTDTALLNYSYPDFDK.V 65.53 4066.89 -3.1 1017.73
323-359 K.DSALEPFYETEDKPWTSVPLTDTALLNYSYPDFDKVK.G 67.68 4294.05 0.6 1074.52
360-367 K.GGTPDLVR.D 42.75 813.43 -2.2 814.44
368-376 R.DYINDHIDR.R 72.13 1159.53 -1.1 580.77
368-377 R.DYINDHIDRR.Y 55.17 1315.63 -3.2 658.82
383-398 K.SEGGKNPALDLLSDFK.G 120.53 1689.86 -1.8 845.93
383-398 K.SEGGKNPAQ(+14.97)DLLSDFK.G 96,7 1704,83 -0,9 569,28
388-398 K.NPALDLLSDFK.G 109.55 1231.64 -1.5 616.83
399-409 K.GVTHDHNEDLK.M 45.3 1263.58 3.3 632.80
410-420 K.MFDWTIQASWK.K 95.7 1411.66 0.2 706.84
410-420 K.M(+15.99)FDWTIQASWK.K 140.6 1427.65 -1.1 714.83
421-444 K.KFELDDSFAIIFYFAADGSTNVTK.E 93.45 2698.32 0.4 900.45
445-455 K.ENYIGSINIFR.G 85.62 1324.68 -0.9 663.35
456-466 R.GTTPTNC(+71.04)ANC(+71.04)R.T 41[a] 1278.55 1.3 640.28
456-466 R.GTTPTNCANC(-2.02)R.T - 1137.27 25 568.72
467-481 R.TQDNLVQEGFVHLDR.F 119.35 1769.87 -1.6 885.94
467-497 R.TQDNLVQEGFVHLDRFIAR.D 45[a] 2257.16 -1.4 753.39
482-497 R.FIARDLDTFDPQAVHR.Y 39[a] 1899.95 -3.5 634.32
486-497 R.DLDTFDPQAVHR.Y 99.75 1412.67 -0.4 707.34
503-518 K.KLSYKVVADDHSVTLK.S 68[a] 1801.99 -1.8 902.00
508-518 K.VVADDHSVTLK.S 74.56 1182.62 -0.8 592.32
508-521 K.VVADDHSVTLKSLR.I 47.91 1538.84 -0.2 513.95
522-539 R.IRVQGRPLHLPPGVSFPR.L 29[a] 2025.17 -3.0 676.06
524-539 R.VQGRPLHLPPGVSFPR.L 33.17 1755.99 -0.6 440.00
543-550 K.NIPIVNFD.D 44.17 930.48 -1.0 466.25
543-554 K.NIPIVNFDDVLD.L 59.95 1372.69 0.0 687.35
543-560 K.NIPIVNFDDVLDLVTGVV.N 49.68 1941.05 -0.6 971.53
543-561 K.NIPIVNFDDVLDLVTGVVN.I 62.20 2055.09 -1.1 686.04
543-563 K.NIPIVNFDDVLDLVTGVVNIG.L 68.36 2225.19 -0.4 1113.60
543-564 K.NIPIVNFDDVLDLVTGVVNIGL.T 64.10 2338.28 -0.8 1170.15
543-565 K.NIPIVNFDDVLDLVTGVVNIGLT.A 71.73 2439.33 0.2 1220.67
543-566 K.NIPIVNFDDVLDLVTGVVNIGLTA.V 62.93 2510.36 -1.0 837.79
543-567 K.NIPIVNFDDVLDLVTGVVNIGLTAV.G 57.72 2609.43 0.1 870.82
543-568 K.NIPIVNFDDVLDLVTGVVNIGLTAVG.A 66.11 2666.45 -0.5 889.82
543-569 K.NIPIVNFDDVLDLVTGVVNIGLTAVGA.T 62.21 2737.49 -1.4 913.50
543-570 K.NIPIVNFDDVLDLVTGVVNIGLTAVGAT.A 78.80 2838.54 -0.9 947.19
543-571 K.NIPIVNFDDVLDLVTGVVNIGLTAVGATA.G 66.09 2909.58 1.8 970.87
543-572 K.NIPIVNFDDVLDLVTGVVNIGLTAVGATAG.V 73.78 2966.60 -0.7 989.87
543-574 K.NIPIVNFDDVLDLVTGVVNIGLTAVGATAGVA.I 71.20 3136.70 0.9 1046.58
[a] to some extend the sample was also evaluated by Proteome Factory AG (www.proteomefactory) giving a alternatively calculated score (supporting information).
a To some extend the sample was also evaluated by Proteome Factory AG (www.proteomefactory.com) giving an alternatively calculated score (Supporting information).
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phobic amino acids (Wu et al., 2010).
The pronounced hydrophobicity of this missing sequence
Thr565–Phe611 is illustrated by a calculated grand average hydro-
pathicity index (GRAVY) of 1.128. For the purpose of comparison,
the GRAVY indices for the protein L-TYR as isolated here (i.e.
Ser2–Thr565) is 0.438 and that of the activated form A-TYR (cov-
ering Ser2–Ser383) is 0.505. Interestingly, the results of a compu-
tational structure prediction program propose that the continuous
hydrophobic part of this missing sequence, namely Ala569 to Ala591,
form an integral membrane helix as illustrated in Fig. 5.
Discussion
A new and improved method for the isolation of latent tyrosi-
nase (L-TYR, PPO4) from white edible mushrooms is presented
here. Particular emphasis was on establishing a method for the
consequent and effective removal of pigments and dying com-
pounds prior to the chromatographic protein puriﬁcation steps.
This very initial preparation step of the mushroom powder is cru-
cial. By the removal of present pigments and their potential precur-
sor-compounds (e.g. substrates like L-tyrosine or tyramine)
interfering and troubling reactions can be prevented in advance.
This removal could be achieved by introducing a compound-
extraction step with highly concentrated PEG solutions (proteins
not soluble) and lowering the pH values of the extraction buffers
from the commonly used values of 6.5–7.0 to 5.3 (Haghbeen
et al., 2004). The protein-extraction following repetitive detergent-
and aqueous polymer-phase separations were decisive for getting
rid of these colored substances (pigments). In this way, the usually
occurring browning reactions could be signiﬁcantly decreased
compared to the established methods for tyrosinase extraction
(Espín and Wichers, 1999; Fan and Flurkey, 2004; Haghbeen
et al., 2004; Nelson and Mason, 1970). The applied method led to
clear protein solutions with low monophenolase activity which
is, however, drastically increased by the presence of SDS in the
enzymatic assay solution (pH 6.5, 2 mM SDS). This result indicates
a high content of L-TYR and low content of A-TYR. Moreover, the
post-browning effect, which otherwise occurs routinely after the
removing of reducing agent (e.g. sodium ascorbate) and temporal
storage, could be prevented by the described method (Fujieda
et al., 2012; Gieseg et al., 1993; Sojo et al., 1998). The lower pH
of 5.3 was helpful in slowing down these browning reactions since
the reported optimum of PPO activity lies at pH values between 6.3
and 7.5. Stability of the enzyme is still given at this pH whereas
autooxidation of diphenols is signiﬁcantly slower at lower pH val-
ues (Jeon et al., 2005). A post-browning reaction taking place after
the SEC due to the change in pH (5.3–7.5) could be prevented, most
likely by the rapid puriﬁcation. This was facilitated by directly con-
necting the SEC with the ﬁrst AEX (DEAE–Sepharose), by the fast
elution protocol, and by the subsequent second AEX (Q-Sepharose)
step effecting the actual isoform (PPO4 from PPO(X), e.g. X = 3)
separation (Fig. 1A). In this way no long temporary storage gaps
are needed and the enzyme can widely be kept in its latent state.
The presumption that this post-browning effect is due to the oxi-
dation of tyrosine residues (by the enzyme itself) to quinones,
can be supported. This is due to the mere fact that the described
extraction and puriﬁcation method suppresses these processes.
Consequently no browning could be visually observed.
In the course of the chromatographic separations there were
several fractions exhibiting SDS-induced monophenolase activity.
The presence of different enzyme species of L-TYR (e.g., partially
cleaved forms) has to be expected. This is illustrated by the high
resolution CEX chromatogram shown in Fig. 1B (A-TYR passed
through, fractions containing #2 and #3 were not characterized).
Even after the ﬁnal puriﬁcation and polishing step (MiniQ,Fig. 1C) several sub-species (cleaved forms) are still present as
shown by the MS data in Fig. 4A, B and Table 1. Are there other po-
tential sources for this remaining diversity?
(i) It is not likely that these forms result from protein cross-
linking or from protein–pigment interactions, or amino acid
backbone oxidation, as the proposed method established all
possible effort to hinder these processes and mass spectro-
metric data does not indicate any supporting evidence for
that. Partial methionine oxidation found in the tryptic maps
(supp. dat.) of L-TYR might occur during sample preparation
as analytical artifacts.
(ii) The observation that the presence (and amount) of differing
protein forms was not signiﬁcantly reduced upon generously
increasing the amount of protease inhibitors. This fact indi-
cates that the proteolytic in vitro cleavage processes occur-
ring during the extraction and puriﬁcation steps were not
the major source of protein heterogeneity (Espín and
Wichers, 1999; Jolley et al., 1969; Van Leeuwen andWichers,
1999; Wichers et al., 1996; Zhang and Flurkey, 1999).
(iii) It is likely that several activated isoforms (predominantly
PPO3 and 4) were already present in the fungi.
However, the heterogeneity observed in the ﬁnally puriﬁed
PPO4 sample (ﬁve sub-species distinguished by MS) is clearly
caused by proteolytic cleavage at the C-terminal side. This process-
ing happens most likely in vivo in pre- or post-harvesting states
(Hammond and Nichols, 1976; Heneghan et al., 2008; Kingsnorth
et al., 2001). In toto, we do not assume that the ﬁnal length of
the polypeptide chain in our ﬁnal puriﬁed protein (or any other
modiﬁcation despite methionine oxidations) was induced by the
analytical puriﬁcation protocol.
Gel electrophoresis resulted in one single band at 62 kDa, show-
ing that the protein sample was properly liberated of any non-tar-
get protein of different size (Fig. 2A). When considering the
theoretical masses of L-TYR (68.3 kDa) and A-TYR (43.5 kDa),
the gel electropherogram of L-TYR indicates that the protein is
not proteolytically activated to a signiﬁcant extent. A sample of
the non-bound (MonoS run) pooled fractions exhibited a strong
colored band (44 kDa) and weak colored band (62 kDa) resulting
from still some L-TYR species contamination. Only faint bands
were detected in the range of small molecular masses (15 kDa),
corresponding to the well characterized protein abLectin (ABL, Uni-
Prot: Q00022, (Carrizo et al., 2005)) and some fragments of PPO4.
ABL had been previously reported to be a contaminant in commer-
cially available mushroom tyrosinase (Flurkey et al., 2008; Rescig-
no et al., 2007). No peptides corresponding to the in literature
(Ismaya et al., 2011) described small subunit attached to A-TYR
of PPO3 (H2L2) were found. Hence, it can be assumed that A-TYR
of PPO4 might not have any afﬁnity to this small subunit and a tet-
rameric structure (H2L2) might not be the case for PPO4.
The RP-HPLC–ESI-MS/MS based analysis of the tryptic peptides
isolated from the 62 kDa band resulted in the unambiguous iden-
tiﬁcation of the enzyme as polyphenol oxidase 4 (PPO4) from A.
bisporus (C7FF05, UniProt.: PPO4) giving a score of 468 (10lgP)
and a sequence coverage of 95% (Table 1 and Fig. 3). Importantly,
peptides outside the core region and belonging to the C-terminal
part (Ser383–Phe611) of the protein could be assigned and veriﬁed
by MS/MS fragmentation data (Fig. 3 and Table 1, peptides beneath
the red line) giving evidence for the existence of PPO4 in a, by def-
inition, latent form. No peptides of the protein region beyond
Ala574 were found.
The ESI-QTOF-MSmeasurements gave evidence for the presence
of ﬁve (sub)-species (A–E) of the intact PPO4 L-TYR, resulting from
proteolytic fringing, exhibiting molecular masses of
B = 64,247.3 Da; A = 64,034 Da; C = 64,546 Da; D = 64,647 Da; and
Fig. 4. ESI-QTOF mass spectra of intact L-TYR and A-TYR. (A) Entire mass spectrum
of L-TYR (PPO4). Panel (a): Peaks of charge states [72] to [68] magniﬁed. (B) Zoomed
section of charge states [63] and [62]. Masses of species A–E: A = 64,034 Da,
B = 64,247.3 Da; C = 64,546 Da; D = 64,647 Da; E = 64,718 Da. Mass differences
between species ﬁt to distinct amino acid composition indicated in amino acid
letter code. Panel (b): Highly zoomed ﬁgure of charge state [63] showing clearly a
shoulder corresponding to mass difference of PPO4 and K9I869. (C) Entire mass
spectrum of A-TYR. Panel (c): Magniﬁed charge state [39] of A-TYR displaying
several potassium adducts (mass differences 39 Da).
Fig. 5. Trans membrane anchor of L-TYR (PPO4). Sequence in the C-terminal tail of
PPO4 (Ala569 to Ala591). For this range a trans-membrane helix structure is predicted
by model calculations (green highlighted area). (For interpretation of the references
to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
S.G. Mauracher et al. / Phytochemistry 99 (2014) 14–25 21E = 64,718 Da, respectively (Fig. 4). Calculating the theoretical mass
of PPO4, including a thioether bridge (Cys80–His82) and accounting
for the presence of an acetylated N-terminus, a disulﬁde bridge and
the eight mutations (PPO4? K9I869) an agreement with the
experimental mass within an error of less than 1.9 Da is attained
when assuming that the peptide backbone of the isolated protein
ranges from Ser2–Thr565 from (Mr calc. = 64,249.2 Da). Moreover,
by analyzing the mass gaps between all the mass spectrometricdetermined species (A–E) the C-terminal end of latent PPO4 could
be assigned. Although a major species (B) ending with Thr565 does
exist in an approximate ratio of 6:1 the C-terminal end seems to
be rather fringed. This is additionally supported by the peptide
mass analyses which found all kinds of possible C-terminal end
peptides. However, the ﬁnal 26 amino acid long C-terminal part ap-
pears to be proteolytically removed in any case (Fig. 3).
The eight in the above mass calculation included mutations at
position Val33? Leu, Ala45? Ser, Val101? Ile, Val121? Ala,
Ser179? Asn, Arg188? Lys, Ala207? Gly and Leu391? Gln can be
found in theMS/MS analysis after tryptic digestion as being present
together with the non-mutated peptides. The agreement between
themolecular mass determined for species A–E in Fig. 4 and the cal-
culated mass for the non-mutated form (Dm = 15.95 Da) of PPO4 is
matchingwith the preceding16 Da shoulder, making it very likely
that both forms, the non-mutated (PPO4) and themutated (K9I869),
are present simultaneously in our sample.
Reasonably, it can be noted, that certain sequence heterogene-
ity (differing strains) is given within our sample as lots of mush-
rooms from several boxes (differing mycelia individuals) were
used for isolating the protein.
22 S.G. Mauracher et al. / Phytochemistry 99 (2014) 14–25The derived mass spectra of A-TYR resulted in one single peak
(other peaks are potassium adducts) with the mass of
43,673.1 Da. Due to fact that one of the sequence disparities
(Leu391? Gln, (Dm = 14.97 Da) is placed on the C-terminal part
of the protein the total mass difference between A-TYR (PPO4)
and A-TYR (K9I869) is only 1.0 Da and is therefore not resolved
in the spectrum. However, a ﬁnal length of A-TYR is concluded to
start with Ser2 and end with Ser383 (including acetylated N-termius
and thioether bridge) giving an unexpected cleavage position since
active PPO3 ends with the common YG-motif located four amino
acids earlier (Ismaya et al., 2011).
Sequence alignment of all six abPPO sequences shows a total
identity between all isoforms of 11.83%, with the highest identity
matches of 76.4% between PPO3 and PPO5 (Weijn et al., 2013).
PPO4 is taxonomically most related to PPO2 with a sequence iden-
tity of 57.6%. The core region entwining and therefore stabilizing
tyrosine-motif (Y-X-Y/F) is located at amino acid position 350–
352, as well as the A-TYR ending YG-motif at position 378–379
(Fig. 3). No disulﬁde bond can occur between the C-terminal part
and the core region (Ser2–Ser383), as the only cysteine in the core
region is Cys80 which forms a thioether bond with His82. The two
cysteines in the C-terminal part (Cys462, Cys465) are located on a
peptide found in the HPLC–MS/MS based peptide analysis likely
exhibiting a disulﬁde bound form (Fig. 3).
PPO4 contains 35 amino acids (corresponding to approx.
2 kDa) more than other abPPO’s (except PPO6) (Weijn et al.,
2013). Homology ends with Gly563 and the 48 amino acid long
(4.2 kDa) ﬁnal part of the C-terminus is unique for PPO4. This
C-tail from Thr565 to Phe611 mainly consists of hydrophobic amino
acids (Grand average of hydropathicity, GRAVY: 1.128). One can
speculate that this might be an indication for a membrane related
origin. Computational model calculations towards secondary
structure prediction for membrane proteins yielded the results
shown in Fig. 5, proposing that the peptide form an integral
membrane helix between the amino acids Ala569 to Ala591. With
such a hydrophobic structure, speciﬁcally PPO4, and unlike to
the other PPOs, could be a membrane-bound protein. However,
only a small part of this putative anchor (maximum four amino
acids and not exceeding Ala574) was found in the isolated protein
when analyzing the tryptic peptides by MS/MS. It is not likely
that larger peptides out of this anchor were present in signiﬁcant
amounts but were overseen by the HPLC–ESI-MS/MS analysis, as
the MS spectrum of the entire protein allows the accurate deter-
mination of the molecular mass of the major species which is in
excellent agreement with a polypeptide chain ranging from Ser2
to Thr565. However, it cannot ﬁnally be excluded that the C-termi-
nal tail was present in vivo and was removed, despite all protease
inhibition efforts, during the early sample preparation and puriﬁ-
cation steps by proteolytic cleavage.
Regarding evidences for additional modiﬁcations, two poten-
tial sites for N-glycosylation are located at position Asn349 (core
region) and Asn441 (C-terminal), respectively. In the HPLC–MS/
MS based peptide analysis, the peptide containing the both
consensus sequences (Asn349, Asn441) were found without
glycosylation.
Further investigations are needed for clarifying in detail the
activation process and mechanism. It is still not clear when and
why the proteolytic cleavage of L-TYR happens and which prote-
ases are responsible. Therefore, their characterization, identiﬁca-
tion, distinction and attribution of all isoforms are necessary.
Also, the occurrence of protein complexes with small subunits,
as was reported for PPO3, and which were deﬁnitely not found
in our investigation, is not yet clariﬁed neither in respect to their
origin nor to function. In respect to all these research aims the
elucidation of the L-TYR crystal structure would be of great
beneﬁt.Concluding remarks
Protein isolation and puriﬁcation from natural sources, particu-
larly from fungi or plants, in a manner that the proteins preserve
their physiological constitution represents a methodological prob-
lem in biochemical research. In this study we present a technique
capable to oppose the causes that are believedbeing themain source
for protein alteration (e.g. formation of polyphenols and dying com-
pounds). The study was focused on highly purifying mushroom
tyrosinase a protein known as intricate to access. The method suc-
ceeded in isolating one out of six distinct isoforms (i.e. PPO4) and
purifying it to identity. Notably, this optimized approach is applica-
ble for many poorly accessible proteins from natural sources.
PPO4 could be identiﬁed and characterized in its latent precur-
sor form by means of mass spectrometry displaying some PTMs,
strain origin related sequence disparities and a somewhat fringed
C-terminus. The exact cleavage position for the enzyme activation
was determined to be located four amino acids behind the com-
mon tyrosinase YG-motif. Additionally, a membrane related origin
could be assigned by computational methods.Experimental
All chemicals used were purchased from Sigma–Aldrich at high-
est available quality.
Mushroom cultivation
Boxes containing fungal inoculated mulch covered with soil
were used for cultivating white button mushroom. They were kept
at constant temperature (15 C) and humidity (95%). Mushrooms
were occasionally harvested when the fruit-body reached
growth-stage ﬁve (Hammond and Nichols, 1976). Fruit-body caps
were discarded and the stipes were lyophilized for 3 days and
grounded to powder for storage at room temperature.
Pigment removal
Mushroom powder was suspended in a 125 mM sodium citrate
buffer, pH 5.3, containing 35% (m/v) polyethylene glycol (PEG-
4000), 25 mM sodium L-ascorbate, 20 mM L-lysine, 50 mM L-pro-
line and 8% (v/v) triton X-114. Phenylmethylsulfonyl ﬂuoride
(PSMF) and benzamidine hydrochloride in dimethylsulfoxide
(DMSO), to a ﬁnal concentration of 1 mM for both, were added.
The suspension was thoroughly mixed by an ultra turrax and sub-
sequently centrifuged at 14,500 rpm (Beckmann XP26, rotor: JLA
16.250) for 10 min at 4 C. The supernatant was discarded and
the pellet resuspended in the above mentioned buffer. This mush-
room powder extraction procedure was repeated twice. The
obtained mushroom pulp, still containing high amounts of triton
X-114 and PEG, was frozen at 80 C for storage (optional).
Protein extraction/puriﬁcation
Frozen mushroom pulp was defrosted at 4 C and suspended in
a 125 mM sodium citrate buffer, pH 5.3, containing 25 mM sodium
L-ascorbate, 20 mM L-lysine, 50 mM L-proline. Again, PSMF and
benzamidine hydrochloride pre-solved in DMSO were added (ﬁnal
concentration 1 mM), as well as two protease inhibitor cocktails
(P8215 0.1% (v/v) and S8830 1 tab/L). The suspension was stirred
for 15 min and subsequently centrifuged (14,500 rpm at 4 C over
10 min). The pellet and the highly viscose triton-phase, covering
the pellet, were discarded. The supernatant was adjusted to 20%
(113 g/L) ammonium sulfate saturation and centrifuged
(14,500 rpm at 4 C over 10 min). The occurring pellet was
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(m/v) in the supernatant at 4 C. After further centrifugation
(14,500 rpm, 4 C, 10 min) the generated PEG phase (upper phase)
containing the non-target proteins was discarded. This step was
followed by the subsequent addition of another 5% (m/v) of PEG-
4000 and centrifugation. This last step was repeated twice. During
the extraction/puriﬁcation process every 45 min a protease inhib-
itor mixture containing PMSF, benzamidine hydrochloride and
the two cocktails P8215/S8830 (Sigma–Aldrich) pre-dissolved in
DMSO was added.
Protein puriﬁcation by fast protein liquid chromatography (FPLC)
All chromatographic puriﬁcation steps were carried out using
an Äkta Puriﬁer (GE Healthcare) placed in a refrigerator to maintain
4 C. In all chromatographic puriﬁcation steps protein amounts
were determined by setting the detection wavelengths to 280 nm
(absorption of aromatic amino acids) and 345 nm (absorption of
type-3 copper sites (Jolley et al., 1969)), respectively. The clear pro-
tein solution yielded by the steps described above was ﬁltrated and
loaded onto a size exclusion (SEC) column (Sephadex G-50, GE
Healthcare, length = 30 cm, i.d. = 5 cm). A 30 mM HEPES buffer,
pH 7.5, containing 10 mM L-lysine and 20 mM L-proline was used
as elution buffer; the ﬂow rate was 10 mL/min. The ﬁrst eluted pro-
tein peak containing high molecular mass fraction was directly
transferred on a straightly connected anion exchange column
(DEAE–Sepharose FF, GE Healthcare, L = 20 cm, i.d. = 2.6 cm) equili-
brated with a 30 mM HEPES buffer, pH 7.5. Proteins were eluted by
stepwise increasing the sodium chloride concentration (1st step:
0.1 M (for 20 min), 2nd step: 0.2 M (for 25 min), 3rd step: 1 M
(for 20 min)) at a constant ﬂow rate of 4 mL/min. The protein frac-
tion eluted in the 2nd step was collected and diluted to a conduc-
tivity below 5 mS/cm by a 20 mM Tris–HCl buffer pH 8.0 and
directly loaded onto an anion exchange column (Q-Sepharose FF,
GE Healthcare, L = 14 cm, i.d. = 2.6 cm) which was equilibrated
analogously. Proteins were eluted by an increasing sodium chlo-
ride gradient depicted in Fig. 1A. Fractions were collected in a size
of 12 mL and all collected fractions were tested photometrically for
monophenolase activity (see enzymatic assay). Two isoforms were
eluted at about 130 mM and 220 mM sodium chloride concentra-
tion, respectively. Fractions containing the ﬁrst eluted protein iso-
form were pooled and ultra ﬁltrated (size exclusion membrane of
30 kDa) centrifuged (4000 rpm) for removing sodium chloride.
Then the protein was loaded on a cation exchange column (MonoS
5/50 GL, GE Healthcare) for further puriﬁcation. Buffer conditions
were 20 mM MES buffer at pH 5.5; proteins were eluted by an
increasing sodium chloride gradient (0–0.13 M) with a very low
slope (1.4 ML1). While the active form of the enzyme (A-TYR)
passed through the column three isoforms (L-TYR), #1, #2 and
#3, were eluted at 11.5 mM, 13 mM and 14 mM sodium chloride
concentration, respectively (Fig. 1B). This time, fractions of the ﬁrst
eluted protein, #1, were pooled and sodium chloride was removed
via ultracentrifugation. The isolated fraction with #1 was further
loaded (20 mM Tris–HCl, pH 9.0) onto an anion exchange column
(MiniQ 4.6/50 PE, GE Healthcare) for removing further non-target
proteins in a ﬁnal polishing step (Fig. 1C). Again, elution was per-
formed by an increasing sodium chloride gradient (20 mM Tris–
HCl, pH 9.0, 0.5 M sodium chloride). The target-protein eluted at
a 47 mM sodium chloride concentration. After this puriﬁcation
step characterization experiments for analyzing the sample com-
position were performed.
Enzymatic assay
The enzymatic monophenolase activity was determined by
monitoring the change in UV absorbance at 305 nm (dopachromeformation (Rodríguez-López et al., 1992)) (Fig. 1D). When measur-
ing the activity of ‘‘active forms’’ of TYR, 10 lL of enzyme solution
were added to 1 mL reaction mixture containing 35 mM potassium
phosphate buffer, pH 6.5, and 0.033 mM tyrosine as substrate. One
unit [U] monophenolase activity was deﬁned as the increase of
1 mAU per minute at a path length of 1 cm at 25 C. When measur-
ing activity of the latent forms of the enzyme, the buffer system
(for better solubility of SDS) was changed to 10 mM sodium phos-
phate buffer, pH 6.5, containing 1.3 mM SDS. Latency was calcu-
lated using the following equation.
latency ½% ¼ 1 activityðSDSÞ½UmL
1
activityðþSDSÞ½UmL1
 !
 100Analytical polyacrylamide gel electrophoresis (PAGE)
Analyses by denaturating SDS–PAGE under reducing (2-
mercaptoethanol) and non-reducing conditions (data for non-
reducing not shown), respectively, were established as described
elsewhere using a total polyacrylamide concentrations of 12% (Lae-
mmli, 1970). Reduced samples were reacted with 3-iodopropiona-
mide for alkylation of Cysteines. Sample load onto the gel was
about 2 lg. Gels were stained with Coomassie Brilliant Blue. The tar-
get protein (L-TYR, 62 kDa) as well as the faint bands (15 kDa) in
the A-TYR lane were cut out and used for protein identiﬁcation.
Imaging of the gels was done with the Gel Doc™ XR of Bio Rad
(Fig. 2).
Protein identiﬁcation and sequence analysis
The gel piece covering the single bands obtained by denaturing
SDS–PAGE (reduced and non-reduced) and containing approxi-
mately 2 lg of protein were used. Proteomic analyses were carried
out after tryptic digestion by use of nanoLC–ESI-MS/MS with a
LTQ-Orbitrap mass spectrometer. In addition samples were also
measured by Proteom Factory AG (www.proteomefactory.com).
Protein identiﬁcation was based on the Mascot Search software
and the NCBInr 110509 database as well as Peaks Studio 6.0 search
software and UniProt/SwissProt database, respectively. Peptide
mass tolerance was 5 ppm and fragment mass tolerance 0.5 Da.
Variable modiﬁcations allowed were oxidation of methionine
and, in the cases of reduced samples, also propionamidation of cys-
teines. For detailed information about the used method- and
search software-parameters see the Supporting information.
Determination of the molecular mass
The mass spectrum of the intact protein was measured using a
nanoESI-QTOF mass spectrometer (maXis 4G UHR-TOF, Bruker)
with a mass resolving power of about 40,000 in the used m/z –
range and a mass accuracy of better than 5 ppm (conﬁrmed by
standard proteins). Prior to MS measurements, the puriﬁed L-TYR
solution was ultra ﬁltrated by centrifugation (10,000 rpm) and
the buffer system was changed to 5 mM ammonium acetate pH
5.5 in order to reduce salt concentration to a minimum. Afterward
acetonitrile (ACN, MS grade) and formic acid were added to a ﬁnal
concentration of 25% (v/v) ACN and 0.05% (v/v) formic acid. Sample
introduction (1 lL sample volume contains about 0.3 lg of protein,
taken from 20 lL total sample volume) was done by using a nano-
spray robotic device (Nanomate, Advion Biosciences).
Computational structure predictions
For the calculation of the GRAVY index (Grand average of hydro-
pathicity) the free online software ProtParam provided by ExP-
24 S.G. Mauracher et al. / Phytochemistry 99 (2014) 14–25ASy.org was used. The secondary structure prediction for mem-
brane proteins was done by using the SOSUI software engine
(ver. 1.11) provided by the University of Nagoya (http://bp.nuap.-
nagoya-u.ac.jp/sosui). The sequence alignment was done by using
the alignment program of uniprot.org.
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